(Q40376542)

20 September 2017

1 reference

title

Molecular genetics: cardiac disease and risk-related genes (English)

1 reference

20 September 2017

1 reference

1 reference

Roberts R

1

1 reference

20 September 2017

1 September 1995

1 reference

20 September 2017

1 reference

20 September 2017

18

1 reference

20 September 2017

IV13-9

1 reference

20 September 2017

9 Suppl 4

1 reference

Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Molecular genetics of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

How many genes in the human genome?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

A second-generation linkage map of the human genome

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Dobutamine vs furosemide in the treatment of cardiac failure due to right ventricular infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Renal and Extrarenal Hemodynamic Effects of Furosemide in Congestive Heart Failure after Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Phentolamine for vasodilator treatment of severe heart-failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Effects of vasodilator therapy for severe pump failure in acute myocardial infarction on short-term and late prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Randomized controlled trial of vasodilator therapy after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Molecular biology of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Angiotensin II–Induced Growth Responses in Isolated Adult Rat Hearts

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Three novel mutations of antithrombin inducing high-molecular-mass compounds

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Linkage of the Angiotensinogen Gene to Essential Hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Molecular genetics. Therapy or terror?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181604

7 January 2021

Identifiers

DOI

10.1002/CLC.4960181604

0 references

PubMed ID

7489615

1 reference

PubMed ID

7489615